BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
13 results:

  • 1. Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.
    Sugimoto R; Uesugi N; Yamada N; Osakabe M; Baba S; Yanagawa N; Akiyama Y; Habano W; Sasaki A; Oda Y; Sugai T
    Diagn Pathol; 2023 Feb; 18(1):24. PubMed ID: 36803776
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gastroblastoma Treated by Endoscopic Submucosal Excavation with a Novel
    Liu Y; Wu H; Wu X; Feng Y; Jiang Q; Wang Q; Yang A
    Curr Oncol; 2022 Nov; 29(11):8862-8873. PubMed ID: 36421350
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. malat1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
    Matuszyk J
    Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress.
    Li T; Zhang X; Cheng L; Li C; Wu Z; Luo Y; Zhou K; Li Y; Zhao Q; Huang Y
    J Cell Mol Med; 2022 Apr; 26(8):2205-2217. PubMed ID: 35166018
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CCL21 activation of the malat1/SRSF1/mTOR axis underpins the development of gastric carcinoma.
    Fu Q; Tan X; Tang H; Liu J
    J Transl Med; 2021 May; 19(1):210. PubMed ID: 34001131
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Propofol facilitates cisplatin sensitivity via lncRNA malat1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LncRNA Expression Profiling in Advanced Resected gastric Adenocarcinoma Tissues.
    Dang Y; Lin L; Ouyang X; Zhang F; Chen S; Wang B; Zhang Z; Chen S; Deng L; Wang W; Wang L; Xiao C; Qi Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850717
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma.
    Banerjee S; Corless CL; Miettinen MM; Noh S; Ustoy R; Davis JL; Tang CM; Yebra M; Burgoyne AM; Sicklick JK
    J Transl Med; 2019 Jul; 17(1):246. PubMed ID: 31362756
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA malat1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z; Si J; Nan J
    Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. malat1 promoted invasiveness of gastric adenocarcinoma.
    Lee NK; Lee JH; Ivan C; Ling H; Zhang X; Park CH; Calin GA; Lee SK
    BMC Cancer; 2017 Jan; 17(1):46. PubMed ID: 28077118
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. malat1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF.
    Wang J; Su L; Chen X; Li P; Cai Q; Yu B; Liu B; Wu W; Zhu Z
    Biomed Pharmacother; 2014 Jun; 68(5):557-64. PubMed ID: 24857172
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.